Wasatch Advisors Inc Exagen Inc. Transaction History
Wasatch Advisors Inc
- $18.5 Billion
- Q2 2024
A detailed history of Wasatch Advisors Inc transactions in Exagen Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 762,259 shares of XGN stock, worth $1.88 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
762,259
Previous 786,895
3.13%
Holding current value
$1.88 Million
Previous $1.25 Million
10.87%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding XGN
# of Institutions
39Shares Held
6.3MCall Options Held
2.5KPut Options Held
200-
Rtw Investments, LP New York, NY1.51MShares$3.73 Million0.05% of portfolio
-
Cowen And Company, LLC891KShares$2.2 Million0.04% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY545KShares$1.35 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.21 Million0.0% of portfolio
-
Morgan Stanley New York, NY482KShares$1.19 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $40.2M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...